Financials
- Market Capitalization 70.85 M
- Employee 17
- Founded 2009
- CEO N/A
- Website www.renovorx.com
- Headquarter Delaware, United States
- FIGI BBG005XWWZK6
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.63
Rapporto prezzo/fatturato
26.43
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4122 | PLRX Pliant Therapeutics, Inc. - Common Stock | 1.15 USD | -0.86% | 0.00% | +6.48% | -29.01% | 71.21 M USD | ||
| 4127 | SPRO Spero Therapeutics, Inc. - Common Stock | 1.21 USD | -0.82% | -2.42% | +0.83% | -39.80% | 70.46 M USD | ||
| 4131 | MNOV MediciNova, Inc. - Common Stock | 1.44 USD | +1.41% | +3.60% | +11.63% | +7.46% | 70.88 M USD | ||
| 4132 | XBIT XBiotech Inc. - Common Stock | 2.30 USD | 0.00% | +0.44% | -0.86% | -32.15% | 70.12 M USD |